Royal Bank of Canada Reaffirms “Outperform” Rating for IDEAYA Biosciences (NASDAQ:IDYA)
Royal Bank of Canada reaffirmed their outperform rating on shares of IDEAYA Biosciences (NASDAQ:IDYA – Free Report) in a research report report published on Tuesday morning, Benzinga reports. Royal Bank of Canada currently has a $61.00 price objective on the stock. Several other equities research analysts have also recently weighed in on the company. Citigroup […]
27 Sep 16:27 · The Markets Daily